Professor Steve Tung of the Department of Mechanical Engineering will speak on "From Microfluidics to Nanofluidics" at the BAE Research Colloquium Seminar at 10:30 a.m. Friday, Oct. 30, in ENGR 219.
mPower Technologies Inc., the consumer products subsidiary of mPhase Technologies, Inc. (XDSL), announced today that consumer pre-orders are now being accepted for the mPower FastCharge. The FastCharge becomes the fifth product in the line.
No larger than a pack of chewing gum, the prototype developed by EPFL's Integrated Systems Laboratory (LSI) is deceptively simple in appearance. But this little black case with two thin tubes sticking out contains some real miniaturized high-tech wonders.
Using microfluidic passages cut directly into the backsides of production field-programmable gate array (FPGA) devices, Georgia Institute of Technology researchers are putting liquid cooling right where it's needed the most - a few hundred microns away from where the transistors are operating.
New chip-based optical sensing technologies developed by researchers at UC Santa Cruz and Brigham Young University enable the rapid detection and identification of multiple biomarkers. In a paper published October 5 in Proceedings of the National Academy of Sciences, researchers describe a novel method to perform diagnostic assays for multiple strains of flu virus on a small, dedicated chip.
WaferGen Bio-systems announced that the Company will commence the commercial launch of the ICELL8™ Single-Cell System at the American Society of Human Genetics (ASHG) Annual Meeting taking place October 6-8, 2015, in Baltimore, MD. The system will create a new standard for single-cell analysis, enabling unbiased isolation of up to 1,800 single cells on a single chip.
A team led by researchers at UC Santa Cruz has developed chip-based technology for reliable detection of Ebola virus and other viral pathogens. The system uses direct optical detection of viral molecules and can be integrated into a simple, portable instrument for use in field situations where rapid, accurate detection of Ebola infections is needed to control outbreaks.
Commercial fluorescence activated cell sorters have been highly successful in the past 40 years at rapidly and accurately aiding medical diagnosis and biological studies, but they are bulky and too expensive ($200,000 -$1,000,000) for many labs or doctors’ offices. Most significantly, these types of cell sorters can present biohazard concerns for operators and may damage cells or alter their properties, making them unfit for further study. To address these issues, researchers at Penn State have developed a new lab-on-a-chip cell sorting device based on acoustic waves.
Rutgers engineers have developed a breakthrough device that can significantly reduce the cost of sophisticated lab tests for medical disorders and diseases, such as HIV, Lyme disease and syphilis.
Scientists have developed a new technique that produces a user friendly, low cost, tissue-engineered pseudo-organ. The chip-based model produces a faithful mimic of the in vivo liver inside a scalable fluid-handling device, demonstrating proof of principle for toxicology tests and opening up potential use in drug testing and personalised medicine.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.